| Inhibition of NHEJ repair by type II-A CRISPR-Cas systems in bacteria A Bernheim, A Calvo-Villamañán, C Basier, L Cui, EPC Rocha, ... Nature communications 8 (1), 2094, 2017 | 86 | 2017 |
| On-target activity predictions enable improved CRISPR–dCas9 screens in bacteria A Calvo-Villamañán, JW Ng, R Planel, H Ménager, A Chen, L Cui, ... Nucleic Acids Research 48 (11), e64-e64, 2020 | 47 | 2020 |
| Tackling AMR from a multidisciplinary perspective: a primer from education and psychology A Calvo-Villamañán, Á San Millán, L Carrilero International Microbiology 26 (1), 1-9, 2023 | 15 | 2023 |
| Are synthetic biology standards applicable in everyday research practice? H Tas, A Amara, ME Cueva, N Bongaerts, A Calvo‐Villamañán, ... Microbial Biotechnology 13 (5), 1304-1308, 2020 | 14 | 2020 |
| Methods for the analysis and characterization of defense mechanisms Against horizontal gene Transfer: Crispr systems A Calvo-Villamañán, A Bernheim, D Bikard Horizontal Gene Transfer: Methods and Protocols, 235-249, 2020 | 1 | 2020 |
| Understanding the sequence determinants of guide RNAs for the activity of dCas9 in bacteria APE Calvo-Villamañán Université Paris Cité, 2021 | | 2021 |
David BikardInstitut PasteurVerified email at pasteur.fr
